A detailed history of Bank Of Montreal transactions in Amylyx Pharmaceuticals, Inc. stock. As of the latest transaction made, Bank Of Montreal holds 105,249 shares of AMLX stock, worth $522,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,249
Holding current value
$522,035
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.62 - $2.71 $170,503 - $285,224
105,249 New
105,249 $199,000
Q2 2023

Aug 02, 2023

BUY
$20.98 - $31.42 $1.24 Million - $1.86 Million
59,230 New
59,230 $1.28 Million

Others Institutions Holding AMLX

About Amylyx Pharmaceuticals, Inc.


  • Ticker AMLX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,533,200
  • Market Cap $290M
  • Description
  • Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...
More about AMLX
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.